EGFR and non-small cell lung carcinoma: Nevertheless, limited but remarkable studies have demonstrated that the detection of EGFR mutations in CTCs of NSCLC patients could mirror tumor heterogeneity [20] and the emergence of clonal evolution under treatment selective pressure [21,22,23,24].